Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 11 04:00PM ET
2.61
Dollar change
-0.01
Percentage change
-0.38
%
Index- P/E- EPS (ttm)-0.97 Insider Own19.60% Shs Outstand34.54M Perf Week3.57%
Market Cap90.15M Forward P/E- EPS next Y-0.97 Insider Trans-10.46% Shs Float27.77M Perf Month-2.25%
Income-26.54M PEG- EPS next Q-0.19 Inst Own20.64% Short Float4.03% Perf Quarter-0.38%
Sales0.01M P/S9014.94 EPS this Y23.10% Inst Trans17.05% Short Ratio8.11 Perf Half Y-36.65%
Book/sh1.09 P/B2.39 EPS next Y-9.30% ROA-69.34% Short Interest1.12M Perf Year-87.99%
Cash/sh0.97 P/C2.68 EPS next 5Y- ROE-88.57% 52W Range1.60 - 22.47 Perf YTD-81.37%
Dividend Est.- P/FCF- EPS past 5Y-23.84% ROI-67.40% 52W High-88.38% Beta-1.65
Dividend TTM- Quick Ratio6.01 Sales past 5Y-24.62% Gross Margin-11462.50% 52W Low63.12% ATR (14)0.18
Dividend Ex-Date- Current Ratio6.01 EPS Y/Y TTM-66.24% Oper. Margin-341437.50% RSI (14)59.80 Volatility3.50% 7.43%
Employees23 Debt/Eq0.06 Sales Y/Y TTM-99.93% Profit Margin-331725.00% Recom1.00 Target Price19.20
Option/ShortNo / Yes LT Debt/Eq0.05 EPS Q/Q1.60% Payout- Rel Volume1.03 Prev Close2.62
Sales Surprise- EPS Surprise-6.02% Sales Q/Q- EarningsAug 14 AMC Avg Volume137.89K Price2.61
SMA2010.13% SMA5015.47% SMA200-46.53% Trades Volume142,175 Change-0.38%
Date Action Analyst Rating Change Price Target Change
Aug-28-24Initiated ROTH MKM Buy $10
Nov-27-23Initiated H.C. Wainwright Buy $35
Sep-12-23Initiated Maxim Group Buy $40
Feb-15-23Initiated The Benchmark Company Speculative Buy $10
Oct-09-24 04:15PM
Sep-03-24 04:01PM
Aug-14-24 09:54PM
04:05PM
Aug-12-24 05:16PM
07:00AM Loading…
Jul-30-24 07:00AM
May-24-24 08:00AM
May-23-24 04:01PM
May-09-24 11:53PM
04:25PM
Apr-26-24 09:35AM
Apr-23-24 09:35AM
Apr-05-24 09:35AM
Apr-04-24 12:00PM
Apr-02-24 07:52AM
07:00AM Loading…
Apr-01-24 07:00AM
Dec-15-23 03:01PM
Nov-27-23 07:00AM
Nov-14-23 05:50PM
Oct-20-23 01:22PM
Oct-11-23 09:00AM
Sep-19-23 03:01PM
Sep-15-23 03:03PM
Sep-14-23 01:21PM
07:00AM
Sep-07-23 04:01PM
Aug-28-23 07:00AM
Aug-14-23 07:00AM
Aug-02-23 04:00PM
01:08AM
10:54AM Loading…
Jul-28-23 10:54AM
Jul-20-23 04:45PM
Jul-10-23 07:00AM
Jun-29-23 07:00AM
Jun-22-23 07:00AM
Jun-12-23 07:00AM
Jun-01-23 05:19PM
May-25-23 04:01PM
May-15-23 07:00AM
Mar-23-23 07:00AM
Jan-25-23 09:00PM
Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay in 2001 and is headquartered in Westlake Village, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Szalay Aladar10% OwnerSep 12 '24Sale2.7331,77786,732632,901Sep 13 06:22 PM
Szalay Aladar10% OwnerSep 13 '24Sale2.5733,08084,946599,821Sep 13 06:22 PM
Tyree James LDirectorSep 11 '24Sale2.601,7304,49947,521Sep 12 08:40 PM
Szalay Aladar10% OwnerSep 11 '24Sale2.6231,37682,227664,678Sep 11 06:23 PM
Szalay Aladar10% OwnerSep 09 '24Sale2.7023,38363,200716,438Sep 11 06:23 PM
Szalay Aladar10% OwnerSep 10 '24Sale2.5120,38451,182696,054Sep 11 06:23 PM
JAMES L TYREEDirectorSep 11 '24Proposed Sale2.511,7304,342Sep 11 04:20 PM
SZALAY 2010 RETAINED ANNUITY T10% OwnerSep 09 '24Proposed Sale2.80140,000392,000Sep 06 07:00 PM
Szalay Aladar10% OwnerSep 03 '24Sale2.0942,81889,614739,821Sep 06 05:08 PM
Szalay Aladar10% OwnerAug 30 '24Sale2.17142,589309,846782,639Aug 30 07:58 PM
Szalay Aladar10% OwnerAug 29 '24Sale1.98107,045211,960925,228Aug 30 07:58 PM
Szalay Aladar10% OwnerAug 28 '24Sale2.0515,91832,6051,032,273Aug 30 07:58 PM
Szalay Aladar10% OwnerAug 27 '24Sale2.1151,630108,8621,048,191Aug 27 07:23 PM
Szalay Aladar10% OwnerAug 23 '24Sale2.2940,00091,4161,099,821Aug 27 07:23 PM
SZALAY 2010 RETAINED ANNUITY T10% OwnerAug 23 '24Proposed Sale2.18400,000872,000Aug 22 05:08 PM
Yu YongVP, Clinical Trial OperationsJun 24 '24Sale2.126,84914,52010,869Jul 08 04:30 PM
Ryder SeanGeneral CounselJun 24 '24Sale2.125,49611,65219,388Jul 08 04:30 PM
Jewett CarolineHead of QualityJun 24 '24Sale2.124,96110,51716,174Jul 08 04:30 PM
Szalay Aladar10% OwnerMay 15 '24Sale3.6617,09462,6241,139,821May 15 05:59 PM
Szalay Aladar10% OwnerMay 14 '24Sale3.5815,42655,2741,156,915May 15 05:59 PM
Szalay Aladar10% OwnerMay 13 '24Sale3.623,44612,4781,172,341May 15 05:59 PM
Szalay Aladar10% OwnerMay 08 '24Sale3.8213,91953,1891,175,787May 09 04:38 PM
Szalay Aladar10% OwnerMay 07 '24Sale3.676,02522,1111,189,706May 09 04:38 PM
Szalay Aladar10% OwnerMay 01 '24Sale3.3033,061109,1611,195,731May 01 06:16 PM
Szalay Aladar10% OwnerApr 30 '24Sale3.1220,53563,9811,228,792May 01 06:16 PM
Szalay Aladar10% OwnerApr 29 '24Sale3.256,40320,7921,249,327May 01 06:16 PM
Szalay Aladar10% OwnerApr 23 '24Sale3.4922,00076,8001,263,794Apr 24 05:50 PM
Szalay Aladar10% OwnerApr 22 '24Sale3.5314,33150,5971,285,794Apr 24 05:50 PM
Szalay Aladar10% OwnerApr 24 '24Sale3.508,06428,2511,255,730Apr 24 05:50 PM
Szalay Aladar10% OwnerApr 16 '24Sale3.5348,683171,8021,322,862Apr 18 05:00 PM
Szalay Aladar10% OwnerApr 17 '24Sale3.7122,73784,4251,300,125Apr 18 05:00 PM
Yu YongVP, Clinical Trial OperationsDec 15 '23Sale13.1632,535428,1800Dec 18 04:15 PM
Tyree James LDirectorDec 13 '23Sale13.229,000118,9693,460Dec 14 08:59 PM
Thomas JohnDirectorDec 13 '23Sale13.389,000120,387463,460Dec 14 08:58 PM
Yu YongVP, Clinical Trial OperationsDec 07 '23Sale11.8536,800435,99532,535Dec 08 05:57 PM
Yu YongVP, Clinical Trial OperationsNov 21 '23Sale10.2618,665191,55569,335Nov 22 04:15 PM
Szalay Aladar10% OwnerOct 25 '23Sale19.405,704110,6381,371,545Oct 26 05:07 PM
Szalay Aladar10% OwnerOct 23 '23Sale19.9749,987998,3651,377,249Oct 25 04:51 PM
Yu YongVP, Clinical Trial OperationsOct 24 '23Option Exercise6.005,20031,200111,335Oct 25 04:15 PM
Yu YongVP, Clinical Trial OperationsOct 24 '23Sale19.115,20099,351106,135Oct 25 04:15 PM
Thomas JohnDirectorOct 16 '23Sale20.713,33369,038472,460Oct 16 06:39 PM